The Interval Between Initiation of Anti-tuberculosis Treatment in Patients with Culture-positive Pulmonary Tuberculosis and Receipt of Drug-susceptibility Test Results

Although mycobacterial culture and the subsequent drug-susceptibility test (DST) for anti-tuberculosis (TB) drugs take several months to complete using solid media, there are no reports on the turnaround times of these tests under clinical conditions. The aim of this study was to determine the interval between initiation of anti-TB treatment and receipt of DST requested at an outpatient clinic. We prospectively enrolled patients with culture-positive pulmonary TB at Seoul National University Hospital from September 2002 to December 2004. Patients were followed up monthly. Mycobacterial cultures were done using Ogawa media at Seoul National University Hospital. DST were performed at the Korean Institute of Tuberculosis. Of the 104 patients enrolled, 54 were male. The median age was 41 yr. The median interval from initiation of anti-TB treatment to receipt of mycobacterial culture results by clinicians was 37 days (range, 0-89 days). The median interval from initiation of treatment to confirmation of DST by requesting clinicians was 80.5 days (range, 28-145 days). Clinicians only received the results of DST more than two months after initiation of treatment when they followed up patients monthly and mycobacterial culture was performed using solid media.

[1]  G. Bai,et al.  Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis , 2005, European Respiratory Journal.

[2]  S. Kim Drug-susceptibility testing in tuberculosis: methods and reliability of results , 2005, European Respiratory Journal.

[3]  S. Muralidhar,et al.  Evaluation of three methods to determine the antimicrobial susceptibility of Mycobacterium tuberculosis. , 2004, The Indian journal of medical research.

[4]  K. Seung,et al.  The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. K. Park,et al.  The treatment of tuberculosis in South Korea. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  Charles L Daley,et al.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. , 2003, American journal of respiratory and critical care medicine.

[7]  E. Tortoli,et al.  Evaluation of Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric BACTEC 460TB Method and the Agar Plate Method of Proportion , 2002, Journal of Clinical Microbiology.

[8]  S. Zanetti,et al.  Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) Automated System for Drug Susceptibility Testing ofMycobacterium tuberculosis , 2001, Journal of Clinical Microbiology.

[9]  M. Casal,et al.  Comparison of Susceptibility Testing of Mycobacterium tuberculosis Using the ESP Culture System II with That Using the BACTEC Method , 2000, Journal of Clinical Microbiology.

[10]  E. Tortoli,et al.  Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems. , 2000, Diagnostic microbiology and infectious disease.

[11]  T. Joint Chemotherapy and management of tuberculosis in the United Kingdom : recommendations 1998 Joint Tuberculosis , 1998 .

[12]  BTS Guidelines Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998 Joint Tuberculosis Committee of the British Thoracic Society* , 1998 .

[13]  Anthony D. Harries,et al.  Treatment of tuberculosis: guidelines for national programmes. Second edition. , 1997 .

[14]  T. Schaberg,et al.  Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media. , 1995, The European respiratory journal.

[15]  D. Astill,et al.  Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens , 1990, Journal of clinical microbiology.

[16]  J. Simmank,et al.  Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex. , 1985, Diagnostic microbiology and infectious disease.

[17]  N. L. Goodman,et al.  Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens , 1983, Journal of clinical microbiology.